Saturday , December 16 2017
Home / Tag Archives: BRAF V600E

Tag Archives: BRAF V600E

October, 2017

June, 2017

November, 2015

  • 23 November

    Roche’s Melanoma Drug Performs Well in Early-Stage Study

    Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced data from the pivotal coBRIM study, which showed that Cotellic (cobimetinib) in combination with Zelboraf (vemurafenib) helped people with BRAF V600E and V600K mutation-positive unresectable or metastatic melanoma live significantly longer (overall survival; OS) than with Zelboraf alone.1 Cotellic plus Zelboraf reduced …